Lincoln Science & Innovation Park has developed a new £1 million pharmaceutical aseptic unit to bring injectable medicines such as chemotherapy, intravenous nutrition and antibiotics to more patients across Lincolnshire.
The development of the unit marks a new milestone in the ongoing relationship between the United Lincolnshire Hospitals NHS Trust, Lincolnshire Co-op and the University of Lincoln, following the founding of the Science & Innovation Park in 2012.
The new unit provides a sterile and controlled environment with specialist equipment installed, in which highly qualified staff can prepare injectable medicines subject to high levels of regulatory control and quality assurance. It will increase physical production capacity, enabling the trust’s pharmacy team to support more patients and teams by creating a range of products that can be transported to areas of greatest need.
The unit is now due to undergo a period of testing to ensure the equipment is all working to standard and is set to deliver products later in the year.
“This project marks the first of our builds at the Science and Innovation Park and a successful partnership with Lincolnshire Co-op,” said Paul Matthew, Director of Finance and Digital for United Lincolnshire Hospital’s NHS Trust. “With many new builds at each of our sites and the opening of units like this there are a lot of improvements happening across our trust that will have a huge impact on the improvement of patient care and will provide better environments for our staff as well as patients.”
Tom Blount, Director of Lincoln Science & Innovation Park, commented: “Lincoln Science & Innovation Park represents a unique collaboration that has unlocked more than £30 million of investment into the innovation ecosystem of Lincolnshire. We are proud to have worked with ULHT on creating this amazing facility, which not only contributes to growth opportunities within our health and care cluster but will have a direct and meaningful impact across the county.”
